Treating the anaemia that occurs in the course of lung cancer leads to a reduction in the patient's debilitation and, consequently, significantly reduces the severity of anxiety and depression.

A randomised, double-blind, placebo and erythropoietin study of 250 patients with anaemia in the course of lung cancer.